RESOURCES
In this first episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement… | Read More
What if a patient breaks or loses their smartphone during the study? What if they… | Read More
Improve your clinical trial efficiency and offer more choice to patients by implementing a BYOD… | Read More
The need to engage patients during clinical trials is no longer debatable; the question is… | Read More
Bring Your Own Device (BYOD) and Provisioned Device (PD) methods will generally work for any… | Read More
We all know clinical trials are more and more complex, involving an increasing number of… | Read More
With so much at stake, consider partnering with an expert of eCOA and DCT! Kayentis… | Read More
The survey, conducted in November 2022, involved 239 site respondents from Europe (47%), Americas (27%),… | Read More
Arthritis is a general term categorized by acute or chronic inflammation of the joints. Arthritis… | Read More
Electronic devices have been systematically provided to participants to report Patient Reported Outcome (PRO) data… | Read More
What rare disease patients and families want is a simpler life. Discover here what makes… | Read More
A patient association in rare diseases is first and foremost families who all have one… | Read More
Cultural differences and individual preferences have a significant impact on healthcare and clinical trial experience…. | Read More
Improve your eCOA data collection and clinical trial efficiency thanks to Kayentis and ClinOne combined… | Read More
Over 90% of rare diseases have no treatment… There are more than 6,000 known rare diseases…… | Read More
Additional funds will be used to scale-up Kayentis’ operations in North America to support clinical… | Read More
Benefit from the alliance between Kayentis and ClinOne and access to a complete range of… | Read More
The rate at which we now collect data in clinical trials is astonishing. With decentralization… | Read More
Responsiveness, reliability, professionalism, friendliness…discover why 95.6% of Kayentis clients recommend Kayentis in 2023! Challenge your… | Read More
Date: March 20 Time: 10am EDT (NA) / 2pm GMT (UK) / 3pm CET (EU-Central)… | Read More
98% of our employees are satisfied or very satisfied with their relationship with their colleagues… | Read More
Despite the evolution in pediatric legislation and a renewed interest in developing therapeutics for pediatric… | Read More
The Participant Feedback Questionnaire (PFQ) is one way to engage patients by asking them about… | Read More
Whilst we hear a lot about working in collaboration with patient representatives, not so many… | Read More
Alliance merges products and services, gaining patients, sites and sponsors unique access to best-in-class eCOA,… | Read More
Basile Trimbur, Medical and Scientific Officer at Kayentis, interviews Trishna Bharadia, Health Advocate & Patient… | Read More
Kayentis has more than eighteen years of success stories with Big Pharma, and has been… | Read More
Increasing the engagement of study patients can be done in multiple ways: one way to… | Read More
If it is important to enable televisits for DCT trials, embedding the feature directly into… | Read More
Date: November 22 Time: 11:15AM CET Location: Paris, France Presentation in French See the full… | Read More
At Kayentis, we: Make sure everyone has the same expectations for the data Think of… | Read More
Essential tips to avoid common pitfalls
Despite the numerous advantages of Decentralized Clinical Trials, reducing on-site visit means that data endpoints… | Read More
Date: October 18Location: PariSanté Campus in Paris OBJECTIVES: Define decentralized clinical trials, provide an update… | Read More
Date: September 12Location: San Antonio, Texas Changing the methods of eCOA data collection, requires a… | Read More
Are you ready for fully remote eCOA in your next DCT trial? Learn how to… | Read More
Immunology studies present specific challenges: their eCOA build can be complex, site staff must play… | Read More
Kayentis (global provider of eCOA and DCT solutions) and RWS (language service provider (LSP) and… | Read More
with our easy-to-use media player embedded in our eCOA app
Provide clinical trial participants with clear and simple information, anywhere, anytime thanks to the Kayentis… | Read More
Using technology to add flexibility to clinical trials can support patients and sites – but… | Read More
Long study duration can have a negative impact on patient compliance As for any clinical… | Read More
Patients taking part in clinical trials need clear and simple information – this is what… | Read More
Clin’form App is the Kayentis BYOD solution, available for patients and caregivers to facilitate decentralized… | Read More
Discover our 2021 employee satisfaction survey results! Strong employee satisfaction and well-being at Kayentis are… | Read More
Dedicated to improve patient experience in clinical trials, Kayentis’ Clin’form solution offers the flexibility to… | Read More
With clinical trials digitalization and decentralization comes the possibility for patients to complete several of… | Read More
The oncology research pathway is paved with numerous challenges, and oncology clinical trials have one… | Read More
In 2020, we implemented a carbon neutral program for all our clinical trials. Our goal?… | Read More
Using Kayentis’ single platform for an enhanced patient experience
Improving patients’ experience using Kayentis unified platform and implementing robust technology integration. Visiting sites remotely… | Read More
Oncology studies present specific challenges that generate complex eCOA build and management: complex study design,… | Read More
Grenoble, France, March 23, 2022 – Kayentis, a global provider of eCOA and Decentralized Clinical… | Read More
Collecting ePRO & eObsRO data via interview mode can be recommended in specific circumstances, according… | Read More
90.8% of our clients are likely to recommend Kayentis to a colleague or a friend…. | Read More
Kayentis offers extensive expertise in dermatology and a solid experience with several typical PROs, ClinROs… | Read More
6 good reasons to select Kayentis
Discover the 6 reasons to select Kayentis and ask us for a demo!
The added value of a single platform DCT trials means bringing the study to the… | Read More
With quickly evolving technologies, electronic Patient Reported Outcomes (ePROs) can now be administered in a… | Read More
We collaborate with patients to characterize their clinical trials expectations and better understand their readiness… | Read More
Many chronic diseases such as invasive cancers, inflammatory disorders, cardiovascular, or central nervous system diseases… | Read More
The clinical trials industry has been facing numerous and long-lasting challenges of patient recruitment and… | Read More
BYOD is a patient-centered method of collecting patients’ data electronically during clinical trials, providing strong… | Read More
COVID-19 caused businesses to adopt new practices, including moving many operations online and leading to… | Read More
The Clin’form eCOA solution is ready for integration with any IRT system: benefit from our… | Read More
Patients are ready to adopt BYOD: 45% of patients prefer BYOD, 40% have no preference,… | Read More
Interview with Trishna Bharadia, Health Advocate & Patient Engagement Advisor on the 1,133 patients survey… | Read More
The decline in R&D efficiency is one of the biggest challenges the pharmaceutical industry is… | Read More
Digital innovation is increasingly penetrating the healthcare industry and technological advances create a new avenue… | Read More
In a perfect world, you would choose your Clinical Outcome Assessments (COAs), write your statistical analysis plan (SAP), license your COAs, get them translated,…
What are the main characteristics that make BYOD a strong feature for decentralized trials? What… | Read More
The best balance for data quality, ease-of-use, and cost for your clinical studies!
7 reasons to choose a web-based back-up solution for your eCOA studies WebCOA is… | Read More
Patients participating in clinical research face a whole range of challenges, and it is particularly… | Read More
Discover the results of a +1,000 patients study conducted in collaboration with patients associations across US and Europe!
The Kayentis team spirit is as strong as ever and COVID-19 cannot beat it! Thank… | Read More
Because of the pandemic, have you felt… …anxious for your/your family’s health? …worried for your… | Read More
Discover the presentation on eCOA setup held by Estelle Haenel, Medical Director @Kayentis, during Clinical… | Read More
88.1% of our customers are likely to recommend Kayentis to a colleague or friend!Thank you… | Read More
Have you anticipated all situations?Discover the key advantages of our WebCOA back-up! Guarantee patient… | Read More
Among numerous clinical study procedures, capturing patients reported outcomes can bring its own set of… | Read More
Although much progress has been made in developing scientific knowledge and conducting clinical research in… | Read More
No longer the “what if” situation: today’s reality and eCOA back-up strategies.How to ensure they… | Read More
Funds will strengthen Kayentis’ digitalization approach in transforming how pharma, investigator sites and patients engage… | Read More
How to anticipate eCOA complexities and ensure a successful launch? Setting up a study with… | Read More
How to anticipate eCOA complexities in multi-year studies & develop best practice to support sites?… | Read More
“Through the quality of the solutions, services, and databases that we provide to sponsors and… | Read More
Carbon-neutral program takes aim at reducing CO2 emissions in clinical trials, particularly phase III, without… | Read More
Discover the 3 key advantages of using a single device for both on-site and home… | Read More
eCOA SETUP: HOW TO ENSURE A SUCCESSFUL LAUNCH BY NAVIGATING COMPLEXITIES Prepare Specifications: how to… | Read More
Focused on eCOA training, this white paper transcribes the discussion from one in a series… | Read More
A small tablet is the perfect choice between a smartphone and a “classic” tablet. A… | Read More
Embrace our spirit! With a 19% increase in new employees in 2019, the Kayentis team… | Read More
There is an extended use of Patient Reported Outcome (PRO) measures in clinical trials used… | Read More
Discover below the 5 reasons to adopt eCOA solutions.Want to learn more about eCOA misconceptions?… | Read More
Although tablets and smartphones are widely used nowadays, not everybody is yet familiar with these… | Read More
Approximately one in every five pediatric clinical study fail1,2 . A 2016 study shows that over… | Read More
Before selecting a PRO for use in a large global trial, it is important to… | Read More
Acute Lymphoblastic or Lymphoid Leukemia (ALL) is a cancer of the lymphocytes that can result… | Read More
With the increasing importance of direct patient input into clinical trials, most protocols combine ePRO… | Read More
When setting up Patient Reported Outcomes (PRO) for Clinical Trials, at some point you will… | Read More
Kayentis sets up incoming EBPs, major contributors in biomedical innovation, as well as its existing… | Read More
Electronic capture of patient data is increasingly replacing the use of paper-based diaries, and electronic… | Read More
Although clinical trials are meant to cover global populations, the pool of patients currently enrolled… | Read More
Although children make up 25% of the world’s population, at least 50% of all drug… | Read More
PROs in ophthalmology trials can either be self-administered by the patient or the responses can… | Read More
Although clinical research stakeholders strive to be patient-centered in their approach, dependence on clinical parameters… | Read More
Incorporating an economic evaluation within a trial provides valuable information for clinical decision making and… | Read More
There seems to be a lot of uncertainty here as people tend to think that… | Read More
Time is of the essence for any clinical study. Nobody wants to lose time when… | Read More
PROs have become a vital part of modern ophthalmology with an increasing focus on PROs… | Read More
A general misconception is that eCOA implementation will generate additional costs. Early investment is required… | Read More
The fear of losing data is more than legitimate. As clinical trial stakeholders you will have… | Read More
As “end users “of innovative technologies, site staff and patients need to embrace the digital… | Read More
Over recent years, as an industry, we seem to have created a paradox: we increase… | Read More
Digital solutions have without a doubt improved both the quality and the quantity of data… | Read More
Proximity will facilitate local and international sponsor access to Kayentis’ eCOA services for mid- to… | Read More
Aware of its responsibility towards the environment, Kayentis decided to help financially two health-focused associations… | Read More
Kayentis announces that it has joined the C-Path’s ePRO Consortium, a nonprofit organization dedicated to… | Read More
eCOA study: the impact of a paper back-up system on data reliability In any eCOA… | Read More
25-year pharma industry veteran and clinical trials expert will strengthen Kayentis’ eCOA offering to sponsors… | Read More
This can only be the result of a balanced and robust Human Resources policy. … | Read More
The results are in! 2018 was marked by an increase of 35% in new employees… | Read More
Any enduring business relationship between a service provider and a client is built on a… | Read More
With a large patient pool and growing pharma market opportunities, study sites in China are… | Read More
Here are 6 reasons to knock at our door! At Kayentis, a global eCOA provider,… | Read More
Estelle Haenel has joined Kayentis as Medical Director. She will help leverage the company’s growing… | Read More
Kayentis is committed to responsible waste management After the promotion of environmentally friendly transport – 2018… | Read More
Interview with Björn Felber – Project Director, Kayentis US In June 2018, Kayentis was strengthening… | Read More
Why is there a need for a back-up solution? In some cases, the eCOA user… | Read More
Moving together towards a better tomorrow At Kayentis, we recognize that we all play a… | Read More
We are proud to announce our collaborative work with OMRON Healthcare on the development of… | Read More
Customer satisfaction survey 2018: The results are in! Rapid growth and diversification of clients brought… | Read More
We are proud to announce that Kayentis has received support from Bpifrance & Europe for… | Read More
The eCOA industry continues to evolve with yet more consolidation amongst traditional providers. Given the… | Read More
Kayentis, expert in eCOA, is stengthening its presence in the US and opening offices in… | Read More
Fort Lauderdale, FL – OmniComm Systems, Inc. (OTCQX: OMCM), a leading… | Read More
Well-being at Kayentis is rated 8/10! We are proud to publish the good results of… | Read More
A multi-platform eCOA solution to address the clinical trial needs of the future Over the… | Read More
Kayentis is a global eCOA vendor created in 2003, 100% dedicated to eCOA. Here is… | Read More
Mobile technology & wearable devices are becoming increasingly prominent in healthcare and clinical research, but… | Read More
Moving on from the “Selection & Evaluation of Technology Service Providers White Paper Part 1”,… | Read More
Joining Kayentis means also joining a company with its own values, a real vision and… | Read More
Digital technology today has become an important tool in facilitating access to and engagement with… | Read More
The European Union (EU) Data Protection Regulations (GPDR), effective from 27 April 2016, will apply to… | Read More
How the Agile mode, implemented in Kayentis’ R&D department, improves the quality of solutions as… | Read More
During a clinical trial, in particular for late phase trials, it becomes increasingly important to… | Read More
‘We are proud to announce that we have been accredited by the French Ministry of… | Read More
Advantages of eCOA: Clinical Outcomes Assessment (COA) data in clinical and epidemiological studies can be… | Read More
After case studies about autoimmune & skin diseases, psoriasis and oncology, Kayentis releases its cardiovascular case… | Read More
Over the last 25 years the collection of clinical research data has moved from paper-based… | Read More
Actigraphy has been used in clinical trials for almost 20 years. Recently their inclusion in… | Read More
In ePRO clinical trials, patients may use tablets to record their data. What if the… | Read More
Electronic tools allow the collection of data (electronic Clinical Outcomes Assessments [eCOA]) from patients, physicians,… | Read More
The past few years have seen a new breakthrough in electronic data capture: the electronic… | Read More
The FDA has provided guidance on methodology to be used for developing and using PRO… | Read More
The constant increase in the volume of clinical data and the emergence of new technologies… | Read More
It is essential that clinicians review PRO data. When patients complete questionnaires using a tablet,… | Read More
The FDA has provided guidance on methodology to be used for developing and using PRO… | Read More
Diverse elements have combined in recent years to make Clinical Outcome Assessments (COAs), and particularly… | Read More
The announcement in May 2016 of the partnership between Kayentis and SecureConsent was just the… | Read More
Kayentis proud to publish the results of its customer satisfaction survey Conducted among more than 60 Kayentis clients,… | Read More
Innovation Capital and Extens finance 3.6 M€ round to accelerate the international growth of Kayentis. Kayentis,… | Read More
Choosing a provider in the clinical trials market is a costly and time-consuming process for… | Read More
Connectivity is key when using electronic Clinical Outcome Assessment (eCOA) tools in clinical studies. But… | Read More
Psoriasis is a chronic immune-mediated inflammatory disease of the skin with various presentations and clinical… | Read More
In recent years the use of electronic Clinical Outcome Assessment (eCOA) tools to improve clinical… | Read More
The patient’s role in clinical trials, as well as the general image of patient care,… | Read More
Several elements have to be respected in order to succeed in achieving a global eCOA… | Read More
Infography COA to eCOA: in many cases this move from COA to eCOA generates cost… | Read More
Benefits generated by a switch from COA to eCOA have already been clearly demonstrated by… | Read More
Authentication is a requirement that can’t be underestimated. It is key that user’s identity is… | Read More
KAYENTIS signs a partnership with eNFORME to combine SecureConsent® eICF solution with Kayentis eCOA’s platform…. | Read More
These phase III clinical studies, supported by Top10 pharma laboratories, will be using the tablet-based… | Read More
Four leading figures in Life Sciences have accepted director Guillaume Juge’s invitation to join the… | Read More
Kayentis finalized in February 2015 a round of funding with the arrival of Extens, a… | Read More